Latest Insider Transactions at Green Sky, Inc. (GSKY)
This section provides a real-time view of insider transactions for Green Sky, Inc. (GSKY). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of GreenSky, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of GreenSky, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 10
2021
|
Gregg Steven Freishtat Director |
BUY
Exercise of conversion of derivative security
|
Indirect |
417,471
+50.0%
|
-
|
|
Jun 10
2021
|
Gregg Steven Freishtat Director |
BUY
Exercise of conversion of derivative security
|
Direct |
177,741
+20.12%
|
-
|
|
Jun 03
2021
|
Gregg Steven Freishtat Director |
BUY
Grant, award, or other acquisition
|
Direct |
33,614
+5.99%
|
-
|
|
Jun 03
2021
|
Robert Sheft Director |
BUY
Grant, award, or other acquisition
|
Direct |
33,614
+7.79%
|
-
|
|
Jun 03
2021
|
Joel M. Babbit Director |
BUY
Grant, award, or other acquisition
|
Direct |
33,614
+15.62%
|
-
|
|
Jun 03
2021
|
Arthur J Bacci Director |
BUY
Grant, award, or other acquisition
|
Direct |
33,614
+25.83%
|
-
|
|
May 14
2021
|
Angela M Nagy SVP, Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,284
-2.29%
|
$6,420
$5.79 P/Share
|
|
May 14
2021
|
Timothy Daniel Kaliban President, Chief Risk Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,272
-0.39%
|
$31,360
$5.79 P/Share
|
|
May 14
2021
|
Gerald R. Benjamin Chief Administrative Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,272
-0.83%
|
$31,360
$5.79 P/Share
|
|
May 14
2021
|
Dennis I Kelly President, Patient Solutions |
SELL
Payment of exercise price or tax liability
|
Direct |
3,136
-1.28%
|
$15,680
$5.79 P/Share
|
|
Mar 15
2021
|
Angela M Nagy SVP, Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
12,020
+17.63%
|
-
|
|
Mar 15
2021
|
Dennis I Kelly President, Patient Solutions |
BUY
Grant, award, or other acquisition
|
Direct |
69,064
+22.0%
|
-
|
|
Mar 15
2021
|
Gerald R. Benjamin Chief Administrative Officer |
BUY
Grant, award, or other acquisition
|
Direct |
69,064
+8.42%
|
-
|
|
Mar 15
2021
|
Andrew Kang EVP and CFO |
BUY
Grant, award, or other acquisition
|
Direct |
89,780
+21.85%
|
-
|
|
Mar 15
2021
|
Timothy Daniel Kaliban President, Chief Risk Officer |
BUY
Grant, award, or other acquisition
|
Direct |
117,404
+6.74%
|
-
|
|
Mar 07
2021
|
Gerald R. Benjamin Chief Administrative Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
17,775
-2.54%
|
$106,650
$6.07 P/Share
|
|
Mar 07
2021
|
Dennis I Kelly President, Patient Solutions |
SELL
Payment of exercise price or tax liability
|
Direct |
8,392
-4.56%
|
$50,352
$6.07 P/Share
|
|
Mar 07
2021
|
Timothy Daniel Kaliban President, Chief Risk Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
12,716
-0.84%
|
$76,296
$6.07 P/Share
|
|
Nov 18
2020
|
Dennis I Kelly President, Patient Solutions |
BUY
Open market or private purchase
|
Direct |
27,000
+12.78%
|
$108,000
$4.07 P/Share
|
|
Nov 13
2020
|
Robert Sheft Director |
BUY
Open market or private purchase
|
Indirect |
1,105,220
+50.0%
|
$3,315,660
$3.47 P/Share
|
|
Nov 13
2020
|
David Zalik CEO and Chairman of the Board |
BUY
Open market or private purchase
|
Direct |
1,105,220
+50.0%
|
$3,315,660
$3.47 P/Share
|
|
Nov 12
2020
|
Angela M Nagy SVP, Chief Accounting Officer |
BUY
Open market or private purchase
|
Indirect |
7,500
+50.0%
|
$22,500
$3.45 P/Share
|
|
Nov 10
2020
|
Gregg Steven Freishtat Director |
BUY
Exercise of conversion of derivative security
|
Direct |
434,880
+46.8%
|
$434,880
$1.08 P/Share
|